TY - JOUR
KW - Humans
KW - *Diabetes Mellitus, Type 2/drug therapy
KW - Glycated Hemoglobin
KW - Cohort Studies
KW - Precision medicine
KW - Dipeptidyl Peptidase 4/therapeutic use
KW - Sodium-Glucose Transporter 2/therapeutic use
KW - Hypoglycemic Agents/therapeutic use
KW - *Dipeptidyl-Peptidase IV Inhibitors/therapeutic use
KW - *Sodium-Glucose Transporter 2 Inhibitors/therapeutic use
KW - Treatment Outcome
KW - Causal forest
KW - Counterfactual prediction
KW - Generalized random forests
KW - Heterogeneous treatment effects
KW - machine learning
KW - Treatment effect heterogeneity
KW - Treatment selection
KW - Type 2 diabetes
AU - A. Venkatasubramaniam
AU - B. Mateen
AU - B. Shields
AU - A. Hattersley
AU - A. Jones
AU - S. Vollmer
AU - J. Dennis
AD - The Alan Turing Institute, British Library, 96 Euston Road, London, NW1 2DB, UK.
University College London, Institute of Health Informatics, 222 Euston Rd, London, NW1 2DA, UK.
University of Exeter Medical School, Institute of Biomedical & Clinical Science, RILD Building, Royal Devon & Exeter Hospital, Barrack Road, Exeter, EX2 5DW, UK.
Department of Statistics, University of Warwick, Coventry, CV4 7AL, UK.
University of Exeter Medical School, Institute of Biomedical & Clinical Science, RILD Building, Royal Devon & Exeter Hospital, Barrack Road, Exeter, EX2 5DW, UK. j.dennis@exeter.ac.uk.
AN - 37328784
BT - BMC Med Inform Decis Mak
C2 - PMC10276367
DO - 10.1186/s12911-023-02207-2
DP - NLM
ET - 2023/06/17
LA - eng
M1 - 1
N1 - 1472-6947
Venkatasubramaniam, Ashwini
Mateen, Bilal A
Shields, Beverley M
Hattersley, Andrew T
Jones, Angus G
Vollmer, Sebastian J
Dennis, John M
MR/W003988/1/MRC_/Medical Research Council/United Kingdom
Journal Article
England
BMC Med Inform Decis Mak. 2023 Jun 16;23(1):110. doi: 10.1186/s12911-023-02207-2.
PY - 2023
SN - 1472-6947
EP - 110
T2 - BMC Med Inform Decis Mak
TI - Comparison of causal forest and regression-based approaches to evaluate treatment effect heterogeneity: an application for type 2 diabetes precision medicine
VL - 23
ER -